#OPCH

6 months ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MA, #DINO, #GEO, #LAZR, #OPCH

#OptionFlow #OptionsTrading #Trading

0 0 0 0

After 10-Year Tenure, Option Care Health CFO Transition: Littelfuse Executive Meenal Sethna Takes Helm Option Care Health appoints Meenal Sethna as EVP and CFO, succeeding Mike Shapiro after his 10-year tenure. Shapiro to remain as Strategic Advisor through Q1 2026. Sethna brings 30+ years experience.

6 months ago

#OPCH Option Care Health Announces Chief Financial Officer Transition

www.stocktitan.net/news/OPCH/option-care-he...

0 0 0 0

Quince Therapeutics Hits Major Milestone: Phase 3 A-T Trial Fully Enrolled, $35M to Fund Critical Results Key Phase 3 NEAT trial completes enrollment with 105 participants. Cash runway extended through Q2 2026. Strategic partnership secured for US launch. See full details.

7 months ago

#QNCX #OPCH Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/QNCX/quince-therape...

0 0 0 0

Quince Therapeutics Prepares Major Rare Disease Launch with 270+ Treatment Centers Nationwide Strategic deal unlocks 90+ pharmacies and 180+ infusion sites for rare disease treatment delivery. Learn how this impacts Quince's commercial launch plans.

7 months ago

#QNCX #OPCH Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

www.stocktitan.net/news/QNCX/quince-therape...

0 0 0 0

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025 Option Care Health (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services, reported strong Q2 2025 financial results. The company achieved net revenue of $1.42 billion, up 15.4% year-over-year, with net income of $50.5 million.Key financial metrics include gross profit of $269.0 million (19.0% of revenue), Adjusted EBITDA of $114.0 million (up 5.2%), and diluted EPS of $0.31. The company repurchased approximately $50.0 million of stock during Q2.Option Care Health updated its FY2025 guidance, projecting revenue of $5.50-5.65 billion, adjusted EPS of $1.65-1.72, and adjusted EBITDA of $465-475 million. The company expects cash flow from operations of at least $320 million.

7 months ago

#OPCH Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

www.stocktitan.net/news/OPCH/option-care-he...

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

8 months ago

#TMDX #PODD #VEEV #OPCH #INSP #BEAM #LFMD #CERT #KRYS #TEM #de58360b-9299-4682-bac3-d7906ea4ff35

Origin | Interest | Match

0 0 0 0

Market Wire News

@marketwirenews.com

10 months ago

News; ( NASDAQ: #OPCH ) (OPCH) Technical Data

0 0 0 0

11 months ago

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #BEKE 14.6x
2. #EPD 11.3x
3. #YPF 4.9x
4. #TOST 3.7x
5. #OPCH 3.1x

#OptionFlow #OptionsTrading #Trading

0 0 0 0

11 months ago

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #YPF 4.3x
2. #OPCH 3.1x
3. #AHCO 3.0x
4. #OLN 3.0x
5. #TOST 2.7x

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024 Option Care Health (NASDAQ: OPCH) has released its Q4 and full-year 2024 financial results, showing strong revenue growth but mixed profitability metrics. Q4 2024 highlights include net revenue of $1,346.4M (up 19.7% YoY), net income of $60.1M, and adjusted EBITDA of $121.6M (up 8.9% YoY).Full-year 2024 performance showed net revenue of $4,998.2M (up 16.2% YoY), though net income decreased to $211.8M from $267.1M in 2023. The company's gross profit margin declined to 20.3% from 22.8% in 2023.For 2025 guidance, Option Care Health projects net revenue of $5.3B-$5.5B, adjusted EBITDA of $450M-$470M, and adjusted EPS of $1.59-$1.69. The company repurchased approximately $90.0M of stock in Q4 2024.

1 year ago

#OPCH Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024

www.stocktitan.net/news/OPCH/option-care-he...

0 0 0 0

@aisfriesland.bsky.social

1 year ago

VesselAlert
Name: FV_Z60_BLUE_ANGEL
MMSI: 205198000
Callsign: OPCH
Type: Fishing
Flag: Belgium
Seen: 21-Jan-2025 00:22:03 CET
Dest.: FISHING
Distance: 18.2 nm
Signal RSSI: -27.9 dBFS
Ship AIS VesselAlert © kx1t - link

0 0 0 0

@aisfriesland.bsky.social

1 year ago

VesselAlert
Name: FV_Z60_BLUE_ANGEL
MMSI: 205198000
Callsign: OPCH
Type: Fishing
Flag: Belgium
Seen: 19-Jan-2025 22:22:27 CET
Dest.: FISHING
Distance: 18.2 nm
Signal RSSI: -24.5 dBFS
Details:
Ship AIS VesselAlert © kx1t - link

0 0 0 0

Option Care Health Unveils $500M Buyback Plan, Projects 20% Q4 Revenue Growth Healthcare provider expects Q4 revenue of $1.35B, announces major share repurchase program amid strong operational performance. 2025 outlook reflects continued growth trajectory.

1 year ago

#OPCH Option Care Health Announces Preliminary Financial Results for Fourth Quarter and Full Year 2024 and Preliminary Financial Expectations for Full Year 2025

www.stocktitan.net/news/OPCH/option-care-he...

0 0 0 0